Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Clinical trial NCT00168818 · COMPLETED

Trial details

NCT number: NCT00168818
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism Arthroplasty, Replacement, Hip

Start date: 2004-11-01
Primary completion: 2006-07-01
Enrollment: 3494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.